The effects of Suboxone withdrawal include the physical and psychological symptoms that occur when your body adjusts to lower levels of buprenorphine/naloxone. For most people, that means some combination of flu-like discomfort, sleep trouble, low mood, and strong cravings — and while the experience varies considerably from person to person, it rarely has to be faced without support.
Deciding to stop or reduce Suboxone is rarely a clear-cut decision, and you are likely trying to understand what comes next.
Perhaps you are working through a taper with your care team and want a clearer sense of each phase. Withdrawal may have already started and you are trying to make sense of what your body is going through. Or you may still be in the early stages of planning, weighing your options before committing to a path. Wherever you are in that process, this is a useful place to start.
The reassuring part is that withdrawal is manageable when you have a clinical plan in place and people who understand what you are going through. This guide covers what to expect at each phase, how physical and psychological symptoms differ, evidence-based approaches to treatment, and the factors that shape your individual experience. Our Suboxone therapy program includes clinical supervision throughout tapering and transitions, so you have guidance and a point of contact at each step of the process.
When your body has adapted to regular buprenorphine use, reducing the dose or stopping entirely disrupts that balance. The result is withdrawal: a cluster of physical and psychological symptoms driven by how the nervous system adapts to the change. Because buprenorphine is a long-acting partial opioid agonist, withdrawal generally has lower immediate intensity than withdrawal from full opioid agonists such as heroin or oxycodone, but it can last longer and follow a more gradual arc.
Buprenorphine’s elimination half-life, reported at roughly 24 to 60 hours in pharmacological literature, helps explain why symptoms can be delayed and why a carefully paced taper often produces less acute discomfort than stopping suddenly, even if the overall timeline stretches longer. For anyone planning to reduce or stop Suboxone, speaking with a clinician before making any changes is the safest first move. Call (866) 394-6123 to speak with a care coordinator.
Suboxone withdrawal produces both physical and psychological symptoms, many of which overlap with general opioid withdrawal. Understanding the full picture helps you recognize what is happening and communicate clearly with your care team.
Physical Symptoms:
Psychological Symptoms:
Gastrointestinal symptoms, yawning, aches, sweating, anxiety, and insomnia are among the most frequently reported in the acute phase. Psychological symptoms, particularly cravings, anxiety, and mood disruption, often outlast the physical phase and require continued support beyond the first week.
When To Seek Immediate Care: If severe vomiting or diarrhea causes significant dehydration, if chest pain or shortness of breath develops, or if suicidal thoughts arise, seek emergency care or contact the 988 Suicide and Crisis Lifeline immediately.
Because buprenorphine has a long half-life, Suboxone withdrawal typically follows a more extended timeline than withdrawal from short-acting opioids. Onset, duration, and peak intensity vary with dose, duration of use, and individual metabolism.
| Phase | Typical Timing | Common Symptoms |
| Early acute | 24–72 hours after last dose | Anxiety, yawning, muscle aches, mild cravings |
| Peak acute | Days 2–4 | Nausea, vomiting, diarrhea, insomnia, intense cravings |
| Subacute | Weeks 2–6 | Fatigue, mood changes, concentration difficulty, sleep disruption |
| Protracted | 1 month+ | Episodic cravings, intermittent insomnia, anxiety, low energy |
Most people find that acute physical symptoms begin to ease after the first week. Psychological symptoms and sleep disruption often take longer to resolve, and some individuals experience protracted symptoms for months following cessation. This extended timeline makes clear that recovery support, not just management of the acute phase, plays an important role in long-term outcomes.
Our medication-assisted treatment program provides continued clinical care across all phases of the withdrawal and recovery process.
Physical and psychological withdrawal symptoms follow different courses and often call for different approaches to manage effectively.
Physical Symptoms (including nausea, muscle aches, sweating, diarrhea, and elevated heart rate) typically appear within the first 24 to 72 hours and peak relatively early. Many respond well to short-term symptomatic medications and clinical management within an outpatient MAT program.
Psychological Symptoms (including anxiety, depression, insomnia, and persistent cravings) often emerge later or persist well beyond the physical phase. These reflect changes in the brain’s reward and stress regulation systems and may continue for weeks to months after the last dose.
For many people, the psychological side of withdrawal is the harder part. Cravings, low mood, and sleep disruption can persist long after the physical symptoms have eased, and the absence of visible symptoms can make it harder to justify continued support. That is precisely when counseling and peer connection matter most. Effective management typically combines a medication review with your prescribing clinician, cognitive behavioral therapy (CBT) or other evidence-based counseling, and peer support groups for ongoing accountability and shared coping strategies.
Pairing medical support with regular behavioral care helps reduce relapse risk and supports the rebuilding of daily routines that make sustained recovery possible. Our dual diagnosis treatment program addresses co-occurring mental health conditions alongside addiction care, which is particularly important for people managing anxiety, depression, or trauma during and after withdrawal.
Suboxone withdrawal differs from withdrawal from full opioid agonists in meaningful ways. Because buprenorphine is a partial agonist with a ceiling effect on opioid activity, early acute symptoms are often less intense than those associated with heroin, fentanyl, or prescription opioids such as oxycodone.
However, buprenorphine’s long half-life means withdrawal is generally more drawn out. Where heroin withdrawal may peak sharply within 24 to 48 hours and largely resolve within a week, Suboxone withdrawal can extend the acute and subacute phases over two weeks or longer, with psychological symptoms persisting further still. This can feel discouraging, especially if you expected a shorter course, but understanding this timeline in advance helps you and your care team plan supports at the right intervals.
For people transitioning from other opioids to buprenorphine, clinicians must time the first dose carefully to avoid precipitated withdrawal, a sudden and severe reaction that can occur if buprenorphine is introduced before enough full opioid agonist has cleared the system. That transition requires careful timing and clinical oversight, not guesswork. How long to wait and how to confirm readiness is something your clinician can walk you through specifically based on what you have been using and for how long.
Many people also carry assumptions about MAT and Suboxone withdrawal that do not match reality, which can make an already difficult process feel more daunting than it needs to be. Learning about common myths about addiction treatment before starting care can help you approach the process with more grounded expectations.
A clinician-supervised taper is generally the safer approach for reducing or stopping Suboxone. Gradual dose reductions give the body time to adjust, reduce acute withdrawal intensity, and preserve the option to slow, pause, or reverse the taper if symptoms worsen or relapse risk increases.
Taper schedules are individualized; there is no single correct rate. Clinicians commonly reduce the dose incrementally and adjust the pace based on symptom response and overall stability. What matters most is that the pace reflects your situation, not just what looks reasonable on paper.
Medications Commonly Used To Manage Withdrawal Symptoms:
If severe withdrawal, suicidal thoughts, or medical instability occur at any point, go to the emergency room or call emergency services immediately.
Our outpatient withdrawal management program provides medically supervised support for people tapering or transitioning off opioid medications in an outpatient setting.
Managing withdrawal effectively means combining medical care with behavioral and psychosocial supports. Neither approach alone is as effective as both together, and the period when you are managing withdrawal is also a valuable window to put longer-term recovery supports in place.
| Therapy | Format | Typical Duration | Primary Goal |
| Cognitive Behavioral Therapy (CBT) | Individual, weekly | 12–16 weeks | Reduce cravings, prevent relapse |
| Contingency Management | Outpatient or group | 8–12 weeks | Reinforce positive behavior change |
| MAT continuation | Ongoing, as indicated | Variable | Lower relapse and overdose risk |
| Group / peer support | Ongoing | Indefinite | Accountability and shared coping |
| Trauma-informed counseling | Individual, weekly | Variable | Address underlying trauma |
For some people, continuing MAT beyond the acute taper is the clinically appropriate path, and that decision is worth discussing with your care team before you are in the middle of withdrawal. If you and your clinician are weighing different medication options, including methadone as a longer-term maintenance approach, our overview of methadone side effects offers useful context on what that option involves and how it compares to buprenorphine-based treatment.
Confirm whether your care team coordinates MAT with counseling and laboratory services, and whether your insurance is accepted. If transportation is a barrier, ask about mobile treatment or virtual intake. To find what is available near you, call (866) 394-6123 or use our clinic finder.
Several factors shape how intense Suboxone withdrawal feels and how significant the risks of relapse and overdose are after stopping. These are not fixed — many can be addressed through clinical planning — but understanding them helps you and your care team make decisions that fit your actual situation rather than a generic template.
Factors That Influence Withdrawal Severity and Duration:
Clinicians use these factors to individualize taper schedules, medication choices, and psychosocial referrals. Longer or higher-dose use generally warrants a slower, more closely supervised taper. Reviewing what to expect from treatment before your first appointment can help you prepare for that conversation and use the time with your care team more effectively.
Overdose Risk After Stopping: Opioid tolerance falls when buprenorphine is discontinued. If someone returns to prior opioid amounts, particularly high-potency opioids such as fentanyl, after a period off medication, the risk of a fatal overdose rises substantially. This is one of the primary reasons clinicians recommend naloxone access and a clear safety plan as part of any discontinuation process. Please discuss naloxone with your clinician before changing or stopping your medication.
Access to a connected treatment network can make a meaningful difference during and after Suboxone withdrawal. When a clinic, mobile unit, and telehealth service are part of the same care system, gaps in treatment are shorter, clinical oversight can continue when circumstances change, and you do not have to start from scratch if your needs shift.
Local clinics and mobile sites reduce the time to urgent assessment or reinduction if withdrawal intensifies or relapse occurs. Faster response lowers the risk of medical complications and helps people stay engaged with treatment rather than cycling out of care entirely.
When you can move between an in-clinic visit, a mobile treatment unit, and a telehealth appointment without changing providers, your care team retains your full history and medication record. Counseling relationships continue, medication adjustments are smoother, and care does not stall when life gets complicated.
At Porch Light Health, our network of clinics, mobile treatment sites, and telehealth services are designed to keep care accessible across Colorado and New Mexico, including rural and frontier communities. To find care close to home, call (866) 394-6123 or visit our clinic finder.
What are the most common physical and psychological symptoms of Suboxone withdrawal?
Physical symptoms commonly include muscle aches, sweating, goosebumps, yawning, runny nose, dilated pupils, nausea, vomiting, diarrhea, and elevated heart rate. Psychological symptoms often include anxiety, low mood, irritability, insomnia, and drug cravings. Autonomic and gastrointestinal symptoms tend to be most intense in the acute phase, while mood disruption, sleep problems, and cravings can persist longer.
How soon after my last dose will withdrawal begin, and when does it peak?
Because buprenorphine has a long half-life, withdrawal typically begins around 24 to 72 hours after the last dose, commonly near 36 hours, with peak intensity in the first several days. This is later than withdrawal from short-acting opioids such as heroin, which often peaks within 24 to 48 hours.
How long does Suboxone withdrawal typically last?
Acute symptoms usually last from several days to two weeks. Subacute symptoms (including fatigue, mood changes, and sleep disruption) may continue for several weeks. A smaller number of people experience protracted symptoms such as intermittent insomnia, anxiety, or low energy for months after stopping. Duration varies with dose, length of use, co-occurring conditions, and the level of clinical support in place.
Is tapering off Suboxone safer than stopping suddenly?
Yes. A medically supervised taper is generally safer because gradual dose reductions lower withdrawal intensity, preserve clinical oversight, and allow the taper to be adjusted if symptoms worsen or relapse risk increases. Stopping abruptly carries higher acute withdrawal intensity and removes the clinical safety net.
Does stopping Suboxone increase my risk of overdose if I relapse?
Yes. Discontinuing buprenorphine lowers opioid tolerance, so returning to prior opioid doses after stopping, especially with high-potency opioids such as fentanyl, raises the risk of overdose significantly. Naloxone access and a safety plan are essential parts of any discontinuation process. Please speak with a clinician before changing or stopping your medication.
If you are thinking about tapering or stopping Suboxone, a supervised plan matched to your medical history is the safest way forward. At Porch Light Health, we can help you build that plan, with clinical oversight, symptom management, and naloxone access built in from the start.
We offer medication-assisted treatment through in-person clinics, mobile treatment sites, and telehealth services across Colorado and New Mexico, so care can reach you wherever you are. We accept Medicaid, Medicare, and major commercial insurance plans. To get started, contact us online or call (866) 394-6123 to speak with a care coordinator.
